Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome
Status:
Withdrawn
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
What affect does the use of a mucoadhesive drug delivery system (Mucolox®) compounded with
clonazepam have in the treatment of burning mouth syndrome?
There are no clinical trials reported in the literature that evaluate the use of a
mucoadhesive vehicle to deliver clonazepam into the oral cavity and treat burning mouth
syndrome. The use of a mucoadhesive may help to increase surface contact and elicit a greater
reduction in symptoms.